Cargando…

Endocrine disorders after heart transplantation: national cohort study

BACKGROUND: Endocrine disorders in patients after heart transplantation (HT) remain understudied. We aimed to assess endocrine profiles and management of HT recipients in the early post- transplant period. METHODS: We conducted a retrospective cohort study on 123 consecutive HT recipients in the Adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakusa, Matej, Vrtovec, Bojan, Poglajen, Gregor, Janez, Andrej, Jensterle, Mojca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171847/
https://www.ncbi.nlm.nih.gov/pubmed/32312324
http://dx.doi.org/10.1186/s12902-020-0533-6
_version_ 1783524149569781760
author Rakusa, Matej
Vrtovec, Bojan
Poglajen, Gregor
Janez, Andrej
Jensterle, Mojca
author_facet Rakusa, Matej
Vrtovec, Bojan
Poglajen, Gregor
Janez, Andrej
Jensterle, Mojca
author_sort Rakusa, Matej
collection PubMed
description BACKGROUND: Endocrine disorders in patients after heart transplantation (HT) remain understudied. We aimed to assess endocrine profiles and management of HT recipients in the early post- transplant period. METHODS: We conducted a retrospective cohort study on 123 consecutive HT recipients in the Advanced Heart Failure and Transplantation Programme between 2009 and 2018. All recipients had per-protocol endocrine follow-up within the first postoperative year. The median time to first post-transplant endocrine follow-up was 3 months (IQR 2–4). We assessed the incidence of vitamin D deficiency, bone mineral density, history of low energy fractures, hypogonadism in male recipients, posttransplant diabetes mellitus, and thyroid and parathyroid function. RESULTS: We enrolled 22 women and 101 men of median age 57 years (IQR 50–63). Post-transplant diabetes mellitus developed in 14 patients (11.4%). 18 of 25 patients (14.6%) with preexisting type 2 diabetes mellitus required intensification of antidiabetic therapy. 38 male patients (40.4%) had hypogonadism. 5 patients (4.6%) were hypothyroid and 10 (9.3%) latent hyperthyroid. Secondary hyperparathyroidism was present in 19 (17.3%), 25-hydroxyvitamin D deficiency in 64 (54.7%) of patients. Osteoporosis was present in 26 (21.1%), osteopenia in 59 (48.0%) patients. 47 vertebral fractures, 3 hip and 1 humerus fractures occurred in 21 patients. Most of the patients had coincidence of two or three disorders, while less than 5% did not have any endocrine irregularities. All patients received calcium and vitamin D supplements. Forty-six patients (37.4%) were treated with zoledronic acid, 12 (9.8%) with oral bisphosphonates. Two patients were treated with teriparatide. CONCLUSIONS: The prevalence of multiple endocrine disorders early after heart transplantation is high. Assessment and management of increased fracture risk and all other potentially affected endocrine axes should be considered as a standard of care in this early period.
format Online
Article
Text
id pubmed-7171847
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71718472020-04-24 Endocrine disorders after heart transplantation: national cohort study Rakusa, Matej Vrtovec, Bojan Poglajen, Gregor Janez, Andrej Jensterle, Mojca BMC Endocr Disord Research Article BACKGROUND: Endocrine disorders in patients after heart transplantation (HT) remain understudied. We aimed to assess endocrine profiles and management of HT recipients in the early post- transplant period. METHODS: We conducted a retrospective cohort study on 123 consecutive HT recipients in the Advanced Heart Failure and Transplantation Programme between 2009 and 2018. All recipients had per-protocol endocrine follow-up within the first postoperative year. The median time to first post-transplant endocrine follow-up was 3 months (IQR 2–4). We assessed the incidence of vitamin D deficiency, bone mineral density, history of low energy fractures, hypogonadism in male recipients, posttransplant diabetes mellitus, and thyroid and parathyroid function. RESULTS: We enrolled 22 women and 101 men of median age 57 years (IQR 50–63). Post-transplant diabetes mellitus developed in 14 patients (11.4%). 18 of 25 patients (14.6%) with preexisting type 2 diabetes mellitus required intensification of antidiabetic therapy. 38 male patients (40.4%) had hypogonadism. 5 patients (4.6%) were hypothyroid and 10 (9.3%) latent hyperthyroid. Secondary hyperparathyroidism was present in 19 (17.3%), 25-hydroxyvitamin D deficiency in 64 (54.7%) of patients. Osteoporosis was present in 26 (21.1%), osteopenia in 59 (48.0%) patients. 47 vertebral fractures, 3 hip and 1 humerus fractures occurred in 21 patients. Most of the patients had coincidence of two or three disorders, while less than 5% did not have any endocrine irregularities. All patients received calcium and vitamin D supplements. Forty-six patients (37.4%) were treated with zoledronic acid, 12 (9.8%) with oral bisphosphonates. Two patients were treated with teriparatide. CONCLUSIONS: The prevalence of multiple endocrine disorders early after heart transplantation is high. Assessment and management of increased fracture risk and all other potentially affected endocrine axes should be considered as a standard of care in this early period. BioMed Central 2020-04-20 /pmc/articles/PMC7171847/ /pubmed/32312324 http://dx.doi.org/10.1186/s12902-020-0533-6 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Rakusa, Matej
Vrtovec, Bojan
Poglajen, Gregor
Janez, Andrej
Jensterle, Mojca
Endocrine disorders after heart transplantation: national cohort study
title Endocrine disorders after heart transplantation: national cohort study
title_full Endocrine disorders after heart transplantation: national cohort study
title_fullStr Endocrine disorders after heart transplantation: national cohort study
title_full_unstemmed Endocrine disorders after heart transplantation: national cohort study
title_short Endocrine disorders after heart transplantation: national cohort study
title_sort endocrine disorders after heart transplantation: national cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171847/
https://www.ncbi.nlm.nih.gov/pubmed/32312324
http://dx.doi.org/10.1186/s12902-020-0533-6
work_keys_str_mv AT rakusamatej endocrinedisordersafterhearttransplantationnationalcohortstudy
AT vrtovecbojan endocrinedisordersafterhearttransplantationnationalcohortstudy
AT poglajengregor endocrinedisordersafterhearttransplantationnationalcohortstudy
AT janezandrej endocrinedisordersafterhearttransplantationnationalcohortstudy
AT jensterlemojca endocrinedisordersafterhearttransplantationnationalcohortstudy